Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended (''SEBI Listing Regulations'')
Awaiting price reaction for this filing.
Piramal Pharma's Board has approved the appointment of Suresh Surana & Associates LLP (an affiliate of global network RSM International) as the company's Statutory Auditors for five consecutive years, from the conclusion of the 5th AGM up to the conclusion of the 10th AGM in 2030. The Board also approved N L Bhatia & Associates, a peer-reviewed firm of Practising Company Secretaries, as Secretarial Auditors for the same five-year period. Both appointments are based on the Audit Committee's recommendation and remain subject to shareholder approval at the AGM. The Board meeting concluded at 5:00 p.m. on June 13, 2025.
This is a routine auditor appointment for the next five-year cycle, pending shareholder nod, with no immediate material impact on shareholders or the stock price. Suresh Surana & Associates brings the backing of RSM International's global audit network, while N L Bhatia & Associates is a long-standing firm for secretarial compliance.